Compounds > 9,10-dimethyl-1,2-benzanthracene
Page last updated: 2024-08-17

9,10-dimethyl-1,2-benzanthracene and Leukemia, Myelomonocytic, Acute

9,10-dimethyl-1,2-benzanthracene has been researched along with Leukemia, Myelomonocytic, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kertai, P; Pocsai, Z; Varga, C1
Ember, I; Kertai, P; Kiss, A; Kozma, L1

Other Studies

2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Leukemia, Myelomonocytic, Acute

ArticleYear
Urinary and serum mutagenicity studies with rats bearing experimental tumours.
    Mutagenesis, 1995, Volume: 10, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Base Composition; Chromatography, Ion Exchange; Dimethylnitrosamine; Disease Progression; Frameshift Mutation; Ion Exchange Resins; Kidney Neoplasms; Leukemia, Myelomonocytic, Acute; Liver Neoplasms, Experimental; Mutagenicity Tests; Nephroma, Mesoblastic; Polymers; Polystyrenes; Polyvinyls; Rats; Rats, Inbred F344; Salmonella typhimurium; Urine

1995
Studies on acute myelomonocytic leukemia in LBF1 rats.
    Cancer letters, 1993, Volume: 68, Issue:2-3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Transformation, Neoplastic; Disease Models, Animal; Female; Gene Expression; Genes, myc; Immunohistochemistry; Leukemia, Myelomonocytic, Acute; Male; Neoplasm Transplantation; Oncogene Protein p21(ras); Rats

1993